Clicky

Multiple Sclerosis and Depression: Are Links Causal?

Relationships between multiple sclerosis (MS) and depression did not appear to be causal, a Mendelian randomization study suggested. Genetic liability to major depressive disorder had no effect on the odds of MS, reported Adil Harroud, MD, of the University of California San Francisco, and colleagues, at ACTRIMS Forum 2021, the annual meeting of the Americas

Multiple Sclerosis and Depression: Are Links Causal? Read More »

Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression Other OTC:EHVVF

MIAMI, Feb. 01, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, is announcing plans to roll out its ketamine home delivery platform known as KetaDASH. The backbone for KetaDASH will be Ehave’s expertise in the area of digital therapeutics, which

Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression Other OTC:EHVVF Read More »

Brain Stimulation Treatment for Depression Could See Future Treatment Targets Such as Smoking Cessation and Dementia

Posted: Feb 15, 2021 / 02:42 PM EST / Updated: Feb 15, 2021 / 02:42 PM EST Sponsored Content by Optimum TMS Transcranial magnetic stimulation (TMS) is electromagnetic stimulation that increases neurotransmitter release in the brain and is used as a treatment for depression. The results are amazing, especially for those who have tried medications

Brain Stimulation Treatment for Depression Could See Future Treatment Targets Such as Smoking Cessation and Dementia Read More »

Otsuka launches pivotal trial of digital therapeutics for depression

Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms. It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking cessation, depression and insomnia. They plan to enroll up to 540 patients in a randomized,

Otsuka launches pivotal trial of digital therapeutics for depression Read More »

Opportunities in Managing Treatment-Resistant Depression and Tardive Dyskinesia

This CME is a follow-up from the 2021 Annual Psychiatric Times® World CME ConferenceTM by PER® Physicians Education Resources, LLC.. Claim Your CME Credit at gotoper.com/go/psych2021print Treatment-resistant depression (TRD) and tardive dyskinesia are common conditions in psychiatry that present challenges in management, and in some cases may be related. Recent US Food and Drug Administration

Opportunities in Managing Treatment-Resistant Depression and Tardive Dyskinesia Read More »

Higher Dietary Fiber Tied to Lower Depression Risk in Young Women

Higher fiber intake may be associated with decreased risk of depression in premenopausal women, new research suggests. Investigators analyzed data from close to 6000 pre- and postmenopausal women. They found that, in premenopausal women, dietary fiber intake was higher among those without depression vs their counterparts with the disorder in a dose-dependent manner. However, there

Higher Dietary Fiber Tied to Lower Depression Risk in Young Women Read More »

Genetic Study of Military Vets Links PTSD to Anxiety and Depressive Disorders

Examining the genomes of more than 250,000 “Million Veteran Program” participants, the researchers identified genetic ties between post-traumatic stress disorder (PTSD) and anxiety and depressive disorders. The study findings were published in Nature Genetics. The researchers conducted genome-wide association studies of PTSD in military veterans of the United States to explore the genetic association with

Genetic Study of Military Vets Links PTSD to Anxiety and Depressive Disorders Read More »